Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01B ANTIMETABOLITES
L01BB Purine analogues
L01BB06 Clofarabine
D03546 Clofarabine (JAN/USAN/INN) <JP/US>
USP drug classification [BR:br08302]
Antineoplastics
Antimetabolites
Clofarabine
D03546 Clofarabine (JAN/USAN/INN)
Therapeutic category of drugs in Japan [BR:br08301]
4 Agents affecting cellular function
42 Antineoplastics
422 Antimetabolites
4229 Others
D03546 Clofarabine (JAN/USAN/INN)
Drug groups [BR:br08330]
Antineoplastic
DG02018 Antimetabolite
DG01958 Nucleic acid derivative, antineoplastic
DG01439 Arabinofuranosyl type antineoplastic
D03546 Clofarabine
Drug classes [BR:br08332]
Antineoplastic
DG02018 Antimetabolite
D03546 Clofarabine
Target-based classification of drugs [BR:br08310]
Enzymes
Oxidoreductases (EC1)
Ribonucleoside-diphosphate reductase
RRM1
D03546 Clofarabine (JAN/USAN/INN) <JP/US>
Transferases (EC2)
DNA polymerase
POLA
D03546 Clofarabine (JAN/USAN/INN) <JP/US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D03546
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D03546
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D03546
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D03546